Clinical genitourinary cancerHumansMaleAdultNeoplasmsGerm Cell and Embryonal
GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment Regimen.
Kenrick Ng, Garima Priyadarshini, Aaron Prendergast, Charlotte Ackerman, Susanna Alexander, Sarah Rudman, Han Hsi Wong, Constantine Alifrangis, Daniel Lawrence, Daniel M Berney, Ewa Nowosinska, Jonathan Shamash
Published: 202610.1016/j.clgc.2025.102468
Abstract
BACKGROUND: Many patients with relapsed germ cell tumors (GCTs) can still be cured with salvage chemotherapy. Oxaliplatin-based therapies may offer reduced toxicity and noncross resistance to cisplatin-based therapies. PET scan response early during…
Preview only. Read the full abstract at the source